{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T09:24:41Z","timestamp":1787304281531,"version":"build-2736575974"},"reference-count":24,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objective: Ovarian hyperstimulation syndrome (OHSS) is a severe complication during controlled ovarian hyperstimulation. Ascites and consecutive hemoconcentration may lead to potentially life-threatening complications like thromboembolic events and the need for intensive care. The use of diuretics is widely used to treat ascites in non-OHSS patients. The aim of this study was to assess whether the use of furosemide in the treatment of OHSS was associated with a higher rate of complications compared to the literature. Methods: In this retrospective cohort study, 502 cases treated from January 2005 to June 2023 for OHSS at the Medical University of Vienna were evaluated regarding the distribution of OHSS severity, average duration of treatment, types and frequency of complications associated with antidiuretic treatment, and predictive factors for paracentesis. Results: The median AMH levels were 5.7 ng\/mL. An antagonist protocol was used in 80% of stimulations. Human Chorionic Gonadotropin trigger was used in 80% of stimulations, with 71.7% of cases being early-onset. The incidence dropped from 8.4% (2006 to 2016) to 3.3% (from 2015 to 2023). The median duration of inpatient treatment was seven days, with about 75% of patients receiving furosemide as a diuretic treatment. Ascites drainage was necessary in 27.9%. None of our patients developed a thromboembolic complication following the furosemide treatment. Conclusions: During the study period, the incidence of OHSS declined, most probably as a result of advances in ovarian stimulation protocols and freezing strategies. In moderate to severe OHSS, standardized diuretic treatment with furosemide was not associated with additional thromboembolic complications as long as patients remain normovolemic.<\/jats:p>","DOI":"10.3390\/jcm15166468","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T08:14:01Z","timestamp":1787300041000},"page":"6468","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Management of Ovarian Hyperstimulation Syndrome with Furosemide at a Tertiary Referral Center\u2014A Retrospective Data Analysis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0544-6960","authenticated-orcid":false,"given":"Daniel","family":"Mayrhofer","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Clinical Division of Gynaecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Walch","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Clinical Division of Gynaecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0012-9029","authenticated-orcid":false,"given":"Marlene","family":"Hager","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Clinical Division of Gynaecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"K\u00fcnz","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Clinical Division of Gynaecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Hoeltz","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Clinical Division of Gynaecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrig","family":"Marculescu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2761-5262","authenticated-orcid":false,"given":"Johannes","family":"Ott","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Clinical Division of Gynaecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9040-1101","authenticated-orcid":false,"given":"Julian","family":"Marschalek","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Clinical Division of Gynaecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2024). Prevention of Moderate and Severe Ovarian Hyperstimulation Syndrome: A Guideline. Fertil. Steril., 121, 230\u2013245.","DOI":"10.1016\/j.fertnstert.2023.11.013"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Sun, B., Ma, Y., Li, L., Hu, L., Wang, F., Zhang, Y., Dai, S., and Sun, Y. (2021). Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF\/ICSI. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.615957"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.ajem.2019.05.018","article-title":"Ovarian Hyperstimulation Syndrome: A Review for Emergency Clinicians","volume":"37","author":"Timmons","year":"2019","journal-title":"Am. J. Emerg. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1055\/s-0030-1265681","article-title":"Treatment of Ovarian Hyperstimulation Syndrome","volume":"28","author":"Aboulghar","year":"2010","journal-title":"Semin. Reprod. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/humupd\/dmg005","article-title":"Review of Clinical Course and Treatment of Ovarian Hyperstimulation Syndrome (OHSS)","volume":"9","author":"Delvigne","year":"2003","journal-title":"Hum. Reprod. Update"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/oxfordjournals.humrep.a138115","article-title":"Prevention and Treatment of Ovarian Hyperstimulation","volume":"8","author":"Schenker","year":"1993","journal-title":"Hum. Reprod."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/09513599309152481","article-title":"Correct Timing of Administration of Diuretic Agents for the Treatment of Ovarian Hyperstimulation Syndrome","volume":"7","author":"Homburg","year":"1993","journal-title":"Gynecol. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2441827","DOI":"10.1080\/14647273.2024.2441827","article-title":"Prevention of Ovarian Hyperstimulation Syndrome (OHSS): British Fertility Society Policy and Practice Guideline","volume":"28","author":"Tsampras","year":"2025","journal-title":"Human. Fertil."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1477-7827-12-59","article-title":"Predictive Factors for Recovery Time in Patients Suffering from Severe OHSS","volume":"12","author":"Nouri","year":"2014","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/bjr\/tqaf064","article-title":"The Application Value of Ultrasound in Ovarian Hyperstimulation Syndrome and Literature Review","volume":"98","author":"Kuang","year":"2025","journal-title":"Br. J. Radiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1556\/650.2018.31152","article-title":"Az Ovarialis Hiperstimul\u00e1ci\u00f3s Szindr\u00f3ma K\u00f3r\u00e9lettana \u00c9s Korszer\u0171 Klinikuma","volume":"159","author":"Murber","year":"2018","journal-title":"Orvosi Hetil."},{"key":"ref_12","first-page":"CD008605","article-title":"Cabergoline for Preventing Ovarian Hyperstimulation Syndrome","volume":"15","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12958-024-01258-y","article-title":"Effect of Aromatase Inhibitors for Preventing Ovarian Hyperstimulation Syndrome in Infertile Patients Undergoing in Vitro Fertilization: A Systematic Review and Meta-Analysis","volume":"22","author":"Jiang","year":"2024","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12958-015-0101-5","article-title":"Comparison of Two Different Methods for Measuring Anti-Mullerian Hormone in a Clinical Series","volume":"13","author":"Hyldgaard","year":"2015","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/humrep\/deh638","article-title":"Early and Late Ovarian Hyperstimulation Syndrome: Early Pregnancy Outcome and Profile","volume":"20","author":"Papanikolaou","year":"2005","journal-title":"Human. Reprod."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","article-title":"Ovarian Hyperstimulation Syndrome in Novel Reproductive Technologies: Prevention and Treatment","volume":"58","author":"Wallach","year":"1992","journal-title":"Fertil. Steril."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1159\/000443829","article-title":"Predictors of Paracentesis in Women with Severe Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study","volume":"81","author":"Nouri","year":"2016","journal-title":"Gynecol. Obstet. Invest."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e1\u2013e575-575.e11","DOI":"10.1016\/j.ajog.2019.02.009","article-title":"Life-Threatening Complications among Women with Severe Ovarian Hyperstimulation Syndrome","volume":"220","author":"Selter","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Huang, K., Shi, Y., Chen, G., Shi, H., and Zhai, J. (2022). Predictive Factors for Recovery Time in Conceived Women Suffering From Moderate to Severe Ovarian Hyperstimulation Syndrome. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.870008"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Liu, J., Liu, F., Xu, W., Zhang, L., Tian, Q., Du, L., Li, S., and Zhang, M. (2025). Risk Prediction Models for Ovarian Hyperstimulation Syndrome: A Systematic Review and Meta-Analysis. BMC Pregnancy Childbirth, 25.","DOI":"10.1186\/s12884-025-07971-9"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12958-025-01388-x","article-title":"Ovarian Tissue Cryopreservation for Fertility Preservation: A Two-Decade Single-Center Experience with 451 Children and Adolescents","volume":"23","author":"Emrich","year":"2025","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"105151","DOI":"10.1016\/j.rbmo.2025.105151","article-title":"Towards a Universal Rapid Warming Protocol for Cryopreserved Human Ovarian Tissue","volume":"51","author":"Einenkel","year":"2025","journal-title":"Reprod. Biomed. Online"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"104792","DOI":"10.1016\/j.rbmo.2024.104792","article-title":"Ovarian Hyperstimulation Syndrome\u2014A Complication of the Past","volume":"50","author":"Ata","year":"2025","journal-title":"Reprod. Biomed. Online"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.fertnstert.2009.01.085","article-title":"Low-Dose Aspirin Therapy to Prevent Ovarian Hyperstimulation Syndrome","volume":"93","author":"Wilhelm","year":"2010","journal-title":"Fertil. Steril."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6468\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T08:34:51Z","timestamp":1787301291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":24,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15166468"],"URL":"https:\/\/doi.org\/10.3390\/jcm15166468","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}